01 1Sichuan Xieli Pharmaceutical Co., Ltd.
02 1Teva Czech Industries s.r.o
01 1INGENOL MEBUTATE
02 1Ingenol Mebutate
01 1China
02 1Israel
NDC Package Code : 61200-037
Start Marketing Date : 2019-10-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 47848-047
Start Marketing Date : 2013-11-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Ingenol Mebutate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ingenol Mebutate, including repackagers and relabelers. The FDA regulates Ingenol Mebutate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ingenol Mebutate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ingenol Mebutate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ingenol Mebutate supplier is an individual or a company that provides Ingenol Mebutate active pharmaceutical ingredient (API) or Ingenol Mebutate finished formulations upon request. The Ingenol Mebutate suppliers may include Ingenol Mebutate API manufacturers, exporters, distributors and traders.
click here to find a list of Ingenol Mebutate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ingenol Mebutate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ingenol Mebutate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ingenol Mebutate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ingenol Mebutate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ingenol Mebutate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ingenol Mebutate suppliers with NDC on PharmaCompass.
We have 2 companies offering Ingenol Mebutate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
